OTC Pharmaceuticals: Global Industry Guide

Products

Full Paper

Full Paper

Price: £999.00
Description: This incisive report provides expert analysis on a global, regional and country basis. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies.



Research Report Overview

Published Date: 01/11/2010
Category: Therapies & Markets

Research Report Decription

pdf icon

Sample Pages:

Click here (PDF)

OTC Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
  • Includes a five-year forecast of the industry

Key Questions Answered:

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Companies Mentioned:

 Bayer AG, GlaxoSmithKline, Johnson & Johnson

Paper Highlights:

  • The global OTC pharmaceuticals market grew by 3.9% in 2009 to reach a value of $110.7 billion.
  • In 2014, the global OTC pharmaceuticals market is forecast to have a value of $131.6 billion, an increase of 18.9% since 2009.
  • Cough and cold preparations is the largest segment of the global OTC pharmaceuticals market, accounting for 17.6% of the market's total value.
  • Europe accounts for 38% of the global OTC pharmaceuticals market value.
  • Johnson & Johnson is the leading player in the global OTC pharmaceuticals market, generating a 12.8% share of the market's value.
  • The global over-the-counter (OTC) pharmaceutical market is highly fragmented, with the top three players holding 23% of the total market by 2014.